Company / Working Capital
Dynavax Technologies Corp. Working Capital History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$770.3M
FY2024
5-year range
$212.6M / $796.9M
FY2020-FY2024
Trend
-3.3%
vs FY2023
Sector context
#55 of 215
Health Care
What the data says
At $770M, Dynavax Technologies Corp.'s working capital ranks #55 of 215 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from $70M in FY2016 to $797M in FY2023.
Based on SEC 10-K filings.
$770M in FY2024 with a 5-year CAGR of +37.7%.
Remained stable around $770M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +22.8%
- 5-Year CAGR
- +37.7%
- 10-Year CAGR
- -
Sector benchmark
#55 of 215 in Health CareTop 26% of 215This company $770.3M Sector average $957.8M
▼
-19.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +37.7%, indicating consistent growth.
- In FY2024, working capital decreased 3.3% year-over-year.
- Ranks #55 out of 215 companies in the Health Care sector.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $770.3M | -3.3% |
| FY2023 | $796.9M | +3.9% |
| FY2022 | $766.9M | +84.3% |
| FY2021 | $416.1M | +95.7% |
| FY2020 | $212.6M | +36.6% |
| FY2019 | $155.6M | +14.1% |
| FY2018 | $136.3M | -24.0% |
| FY2017 | $179.4M | +157.9% |
| FY2016 | $69.6M | -59.4% |
| FY2015 | $171.2M | +59.7% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026